An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases.

Mordoh A, Aris M, Carri I, Bravo AI, Podaza E, Pardo JCT, Cueto GR, Barrio MM, Mordoh J

Open source

DOI
10.3389/fimmu.2022.842555
Published
2022
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2022.842555,
  title = {An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases.},
  author = {Mordoh A and Aris M and Carri I and Bravo AI and Podaza E and Pardo JCT and Cueto GR and Barrio MM and Mordoh J},
  year = {2022},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2022.842555},
  url = {https://doi.org/10.3389/fimmu.2022.842555}
}

RIS

TY  - JOUR
TI  - An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases.
AU  - Mordoh A
AU  - Aris M
AU  - Carri I
AU  - Bravo AI
AU  - Podaza E
AU  - Pardo JCT
AU  - Cueto GR
AU  - Barrio MM
AU  - Mordoh J
PY  - 2022
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2022.842555
UR  - https://doi.org/10.3389/fimmu.2022.842555
ER  - 

APA

A, M., M, A., I, C., AI, B., E, P., JCT, P., GR, C., MM, B., & J, M. (2022). An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2022.842555

Source records